Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Irina Halvadzhiyan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Body Composition of Children with Type 1 Diabetes: A 20-Year Single-Center Comparative Study

    by Irina Halvadzhiyan, Stanimira Elkina, Chayka Petrova

    Background: Puberty in children with type 1 diabetes (T1D) is associated with increased insulin requirements, reduced insulin sensitivity, and changes in body composition. Objective: To evaluate body mass index (BMI) and body composition in children with T1D and compare the findings with data obtained 20 years earlier. Materials and Methods: This retrospective comparative study included two historical cohorts of children with type 1 diabetes (T1D) examined at the same tertiary diabetes center 20 years apart. A total of 293 participants were included: 145 age-matched children assessed in 2003 and 148 children assessed in 2023 (mean age 12.15 ± 4.42 years). Body mass index (BMI), fat mass (FM), and fat-free mass (FFM) were analyzed using bioelectrical impedance analysis, and the effects of insulin therapy, continuous glucose monitoring (CGM), physical activity, and family history of obesity were evaluated. Results: Mean BMI in 2023 was 19.85 ± 4.47 kg/m2; 85.8% of participants had normal body weight, 6.0% were overweight, and 8.1% had obesity. Children with a family history of obesity had higher BMI values than those without such history (23.2 ± 6.0 vs. 19.4 ± 4.3 kg/m2; p < 0.05). The highest BMI values in both sexes were observed in patients with T1D duration of 5–10 years. Compared with 2003, contemporary prepubertal boys had higher BMI values. Higher FM percentages in girls compared with boys were preserved. CGM use was associated with lower HbA1c, lower insulin dose requirements, and lower BMI values (all p < 0.05). Conclusions: Significant sex- and time-related differences in BMI and body composition were identified in children with T1D. CGM use was associated with better metabolic control and a more favorable body composition profile.


  • Open Access

    Diagnostic Challenges in Severe Electrolyte Imbalance in Early Infancy: A Case Report of Secondary Pseudohypoaldosteronism

    by Stanimira Elkina, Irina Halvadzhiyan, Venetsiya Bozhanova

    Background: Secondary pseudohypoaldosteronism (PHA) is a rare, transient condition caused by renal tubular resistance to aldosterone, most commonly associated with urinary tract infection (UTI) and/or congenital anomalies of the kidney and urinary tract (CAKUT). It mimics primary adrenal disorders, presenting with life-threatening electrolyte disturbances in early infancy. Case Presentation: We report a male infant admitted twice within the first four months of life with severe dehydration, hyponatremia, hyperkalemia, metabolic acidosis, and acute kidney injury (AKI). Urine cultures grew Klebsiella pneumoniae and later Escherichia coli. Imaging studies demonstrated obstructive CAKUT, including posterior urethral valves, bilateral megaureters, hydronephrosis, and bladder diverticulosis. Congenital adrenal hyperplasia was excluded. Further evaluation showed markedly elevated plasma renin and aldosterone levels, confirming secondary PHA. The patient was successfully treated with intravenous fluids, electrolyte correction, and antibiotic therapy. Subsequently, oral sodium chloride and bicarbonate supplementation were added. Stepwise surgical correction of the urinary tract anomalies was initiated. Conclusions: Secondary PHA should be considered in infants presenting with failure to thrive, dehydration, hyponatremia, and hyperkalemia, particularly in the presence of UTI or CAKUT. Early recognition and differentiation from primary adrenal disorders are essential to prevent life-threatening complications. Prompt correction of electrolyte imbalance and management of the underlying urinary tract pathology are crucial for favorable outcomes.

  • Open Access

    Chronic Sclerosing Osteomyelitis of Garré of the Femur in a 4-Year-Old Girl Caused by Coagulase-Negative Staphylococci: A Case Report

    by Nikolay Balgaranov, Stanimira Elkina, Irina Halvadzhiyan, Teodora Marinova-Bulgaranova

    Background: Chronic sclerosing osteomyelitis of Garré (CSO) is a rare, non-suppurative form of primary chronic osteomyelitis characterized by reactive periosteal bone formation and cortical thickening. It most commonly involves the mandibular bones, whereas long-bone localization is uncommon. Material and Methods: We report a 4-year-old girl who developed progressive right thigh pain and limping six months after receiving intramuscular ampicillin injections. Subsequent evaluation revealed femoral changes consistent with chronic sclerosing osteomyelitis. Surgical decompression and targeted antimicrobial therapy were performed. Results: Microbiological analysis of intraoperative specimens obtained prior to antibiotic therapy yielded Staphylococcus epidermidis (S. epidermidis) and Staphylococcus capitis (S. capitis). After three years of follow-up, the patient exhibited no functional impairment or growth disturbance of the affected limb. Conclusions: Although coagulase-negative staphylococci (CoNS) are commonly regarded as skin commensals, their repeated isolation from deep surgical specimens, together with clinical findings and response to treatment, raises the possibility of their involvement in the disease process in this case.

  • Open Access

    Hypothyroid Myopathy—A Rare Case from Paediatric Practice

    by Stanimira Elkina, Ventsislava Stoyanova, Irina Halvadzhiyan, Chayka Petrova

    Hypothyroid myopathy is uncommon in childhood. Severe hypothyroid myopathy observed in paediatric practice is a part of Kocher–Debré–Semelaigne syndrome (KDSS, OR-PHA:2349), a rare disorder characterised by muscular pseudohypertrophy and long-standing moderate-to-severe hypothyroidism. We present a pubertal girl with KDSS diagnosed with severe myopathy and significantly limited mobility and progressively increasing pains in the lumbar area, hip joints, and the lower limbs. Additionally, the patient presented metabolic syndrome with severe obesity, growth retardation, and educational difficulties. In this case, adequate hormone replacement therapy with Levothyroxine evoked full recovery of the myopathy and a significant reversal in the patient’s general condition. In conclusion, emphasizing the knowledge related to KDSS can improve the diagnosis and prognosis of the condition.


  • Open Access

    Growth Hormone Treatment: First Results of the Partnership Program for the Establishment of a Growth Center at the University Clinic of Pediatrics –Pleven

    by Irina B. Halvadzhiyan

    In March 2018, in the Clinic of Pediatrics of the University Hospital “G. Stranski ”- Pleven, we have created a Center for diagnosing and treating children with growth disorders, in active collaboration with an established expert center. During the study, 53 children with height <-2 SDS were referred to the newly established Growth Center. The diagnoses of children receiving treatment with growth hormone (GH) were made in clinical settings based on the history, physical status, auxological assessment, imaging studies, basal and stimulated hormone tests, genetic tests. The children‘s mean age was 9.7 ± 4.5 years, with a significant gender difference (p>0.05), living mainly in cities. For 18 months, we treated a total of 11 children (54.5% male) with an average age at the start of GH therapy of 8.1 ± 4.4 years and an average growth velocity of 10.3 ± 7.7 cm/year. Treatment with GH was introduced in Pleven after successfully establishing the Growth Center in the Clinic of Pediatrics. The first results showed a significant increase in the number of diagnosed and treated children whose follow-up we found an acceleration in growth and bone maturation, positive body composition changes, and lack of side effects from the treatment.